PL2922571T3 - Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran - Google Patents

Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran

Info

Publication number
PL2922571T3
PL2922571T3 PL13801495T PL13801495T PL2922571T3 PL 2922571 T3 PL2922571 T3 PL 2922571T3 PL 13801495 T PL13801495 T PL 13801495T PL 13801495 T PL13801495 T PL 13801495T PL 2922571 T3 PL2922571 T3 PL 2922571T3
Authority
PL
Poland
Prior art keywords
metalloporphirines
carborate
pharmaceutical form
form containing
pharmaceutical
Prior art date
Application number
PL13801495T
Other languages
English (en)
Inventor
Chris Beattie
James Rennie
Anne Wadsworth
Original Assignee
Morex Development Partners Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morex Development Partners Llp filed Critical Morex Development Partners Llp
Publication of PL2922571T3 publication Critical patent/PL2922571T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL13801495T 2012-11-23 2013-11-22 Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran PL2922571T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1221125.6A GB201221125D0 (en) 2012-11-23 2012-11-23 Pharmaceutial formulations
EP13801495.6A EP2922571B1 (en) 2012-11-23 2013-11-22 Pharmaceutical formulations comprising carborane-containing metallo-porphyrins
PCT/EP2013/074490 WO2014079977A1 (en) 2012-11-23 2013-11-22 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PL2922571T3 true PL2922571T3 (pl) 2018-03-30

Family

ID=47560584

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13801495T PL2922571T3 (pl) 2012-11-23 2013-11-22 Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran

Country Status (20)

Country Link
US (1) US9358290B2 (pl)
EP (1) EP2922571B1 (pl)
JP (1) JP6279599B2 (pl)
KR (1) KR20150086283A (pl)
CN (1) CN104853777B (pl)
CA (1) CA2890271A1 (pl)
CY (1) CY1119713T1 (pl)
DK (1) DK2922571T3 (pl)
ES (1) ES2646010T3 (pl)
GB (1) GB201221125D0 (pl)
HR (1) HRP20171652T1 (pl)
HU (1) HUE035198T2 (pl)
LT (1) LT2922571T (pl)
NO (1) NO2922571T3 (pl)
PL (1) PL2922571T3 (pl)
PT (1) PT2922571T (pl)
RS (1) RS56499B1 (pl)
SI (1) SI2922571T1 (pl)
SM (1) SMT201700512T1 (pl)
WO (1) WO2014079977A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
AU2002340676B2 (en) 2001-11-09 2008-12-11 Valeant Pharmaceuticals International, Inc. Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
WO2009031489A1 (ja) * 2007-09-03 2009-03-12 Kawamura Institute Of Chemical Research ナノ構造複合体被覆型構造物の製造方法、ナノ構造複合体被覆型構造物及びこれを用いるリアクター
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Also Published As

Publication number Publication date
RS56499B1 (sr) 2018-01-31
ES2646010T3 (es) 2017-12-11
HK1209339A1 (en) 2016-04-01
SI2922571T1 (sl) 2017-12-29
HRP20171652T1 (hr) 2017-12-15
US20150297717A1 (en) 2015-10-22
KR20150086283A (ko) 2015-07-27
CN104853777A (zh) 2015-08-19
CA2890271A1 (en) 2014-05-30
HUE035198T2 (hu) 2018-05-02
NO2922571T3 (pl) 2018-02-03
SMT201700512T1 (it) 2018-01-11
EP2922571A1 (en) 2015-09-30
US9358290B2 (en) 2016-06-07
EP2922571B1 (en) 2017-09-06
PT2922571T (pt) 2017-11-07
CN104853777B (zh) 2019-03-08
JP6279599B2 (ja) 2018-02-14
CY1119713T1 (el) 2018-06-27
WO2014079977A1 (en) 2014-05-30
LT2922571T (lt) 2017-11-10
GB201221125D0 (en) 2013-01-09
DK2922571T3 (da) 2017-11-13
JP2016500090A (ja) 2016-01-07

Similar Documents

Publication Publication Date Title
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK3679922T3 (da) Sprøjte
DK3381444T3 (da) Sprøjte
EP2832391A4 (en) SYRINGE
DK2897594T3 (da) Farmaceutisk sammensætning
EP2913076A4 (en) SYRINGE
EP2883547A4 (en) MEDICINE
DK2854765T3 (da) Farmaceutisk pemetrexed-opløsning
BR112015002683A2 (pt) recipiente
LT2908836T (lt) Farmacinė kompozicija, turinti kurkumino
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
BR302012003979S1 (pt) Configuração aplicada em fármaco
PL2922571T3 (pl) Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran
BR112014021433A2 (pt) formulações farmacêuticas
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
ECSP12011630A (es) Formulación farmacéutica
FR2986420B1 (fr) Pillulier
TH1401006714B (th) แคปซูล
UA25455S (uk) Флакон для лікарських засобів
UA25454S (uk) Флакон для лікарських засобів
UA24159S (uk) Флакон для лікарських засобів
UA24201S (uk) Флакон для лікарських засобів
UA25275S (uk) Флакон для лікарських засобів
UA24158S (uk) Флакон для лікарських засобів
EP2885023A4 (en) SYRINGE